Supplements

Thymosin Alpha 1 (10MG)

Overview

This product scores Average due to promising immune efficacy balanced against regulatory and quality concerns. Effectiveness (75) reflects robust PubMed evidence from reviews (e.g., PMID 33362999, 38308608) showing TA1 enhances T-cell maturation and cytokine production in trials for hepatitis (1.6mg 2x/week) and cancer, with over 11,000 patients demonstrating benefits, though general supplement claims lack RCTs. Safety (55) is tempered by FDA's Category 2 status for compounding risks (immunogeni

Key strengths

Our analysis

Thymosin Alpha 1 offers evidence-based immune support for specific conditions like viral infections or cancer adjunct, but its unapproved status and FDA compounding risks make it unsuitable as a general supplement. Use only under medical supervision with verified purity. Average rating reflects balanced efficacy against regulatory hurdles.

Frequently asked questions

Is Thymosin Alpha 1 (10MG) worth buying?
Thymosin Alpha 1 (10MG) has a Verify Influencers trust score of 43/100 based on ingredient quality, clinical evidence, and third-party testing.
What is the trust score for Thymosin Alpha 1 (10MG)?
Thymosin Alpha 1 (10MG) scored 43 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.

Browse all scored products · How products are scored